Clinical trials
Showing of 24 results
University Hospitals Awarded $7 Million by PCORI to Study Endovascular Thrombectomy in Patients Presenting Beyond 24 Hours
Dr. Amrou Sarraj will lead the study, which aims to provide deterministic evidence of clinical benefit due to addition of endovascular thrombectomy to standard medical care in this population.
Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
Study is being done through an agreement between UH and Luminary Therapeutics.
University Hospitals Rainbow Babies & Children’s Sickle Cell Disease Patient to Represent the Hospital in Washington, DC
During the 2024 Children’s Hospital Association Family Advocacy Day Canaan Evans and his mom, Arenda will discuss their experience of participating in a clinical trial and undergoing an investigational treatment he says changed his life.
Cleveland Innovation District Partners Exceeding Many Targets Set by State and JobsOhio
25 examples of progress showcase the impact of successful collaboration.
International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.
The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
The Therapeutics Accelerator (the ‘Accelerator’) will identify, fund and advance innovative projects from academic partners in the U.K. and U.S. with the goal to deliver 40 new potentially life-changing therapies for rare diseases into clinical...
FDA Approves Minimally Invasive Therapy Shown to Save the Legs of Severe Vascular Disease Patients from Amputation
Research led at University Hospitals demonstrated LimFlow therapy helped 76 percent of patients at risk for major amputation keep their leg.
Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial
Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.